REMEDIUMREMEDIUM1561-59362658-3534Joint-Stock Company Chicot132110.21518/1561-5936-2018-11-29-32Original ArticleCough and cold combinations market: what do Russians choose?ProzherinaJulianoemail@neicon.ruRemedium1112201811293218032022Copyright © 2018,2018In Russia, the incidence of influenza and acute respiratory diseases (ARVI) increases more often in the winter period [1]. According to WHO recommendations, the use of symptomatic therapy (antipyretic, antitussive drugs, vitamins, etc.) is considered sufficient for most people to treat typical non-severe influenza. However, in recent years practitioners give preference to the medications that have a complex effect on the ARVI and flu symptoms [2]. In this regard, an analysis of the cough and cold combinations market seems particularly relevant on the threshold of the new epidemic season.cough and cold combinationsAnviMax®грипп и ОРВИкомбинированные противопростудные препаратыАнвиМакс®flu and АШ1.Грипп у взрослых. Министерство здравоохранения РФ. 2017.2.Лусс Л.В. Комплексный подход к терапии гриппа и ОРВИ. Медицинский совет. 2017; 5: 168-173.3.Инструкция по применению к препарату АнвиМакс®.4.Лазаревич И.Л. Фармакологические и нефармакологические методы лечения ОРВИ. Медицинский совет. 2015; 3: 78-82.